Articles from Envol Biomedical

Envol Biomedical Adopts TurboLIMS To Enable Real-Time Access to Research Results
Resero Analytics and Envol Biomedical today announced that Envol has licensed TurboLIMS, Resero's electronic data capture (EDC) system for nonclinical studies. Envol is validating TurboLIMS for its GLP studies, including against 21 CFR Part 11 requirements. Envol scientists helped shape the software by setting its laboratory requirements and testing it in their own facility.
By Envol Biomedical · Via Business Wire · November 13, 2026